Home › Compare › CYTHW vs EPRT

CYTHW vs EPRT: Dividend Comparison 2026

CYTHW yields 6250.00% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYTHW wins by $547038161900822.13M in total portfolio value
10 years
CYTHW
CYTHW
● Live price
6250.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547038161900822.19M
Annual income
$530,345,833,482,145,900,000.00
Full CYTHW calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — CYTHW vs EPRT

📍 CYTHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYTHWEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYTHW + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CYTHW pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYTHW
Annual income on $10K today (after 15% tax)
$531,250.00/yr
After 10yr DRIP, annual income (after tax)
$450,793,958,459,824,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, CYTHW beats the other by $450,793,958,459,824,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYTHW + EPRT for your $10,000?

CYTHW: 50%EPRT: 50%
100% EPRT50/50100% CYTHW
Portfolio after 10yr
$273519080950411.13M
Annual income
$265,172,916,741,072,950,000.00/yr
Blended yield
96.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

CYTHW
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-46.3
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYTHW buys
0
EPRT buys
0
No recent congressional trades found for CYTHW or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYTHWEPRT
Forward yield6250.00% ✓3.97%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$547038161900822.19M ✓$64.3K
Annual income after 10y$530,345,833,482,145,900,000.00 ✓$13,170.85
Total dividends collected$545916230838674.88M ✓$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: CYTHW vs EPRT ($10,000, DRIP)

YearCYTHW PortfolioCYTHW Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$635,700$625,000.00$11,212$512.01+$624.5K → CYTHW
2$37,812,208$37,132,009.35$12,689$692.09+$37.80M → CYTHW
3$2,104,624,511$2,064,165,448.17$14,521$944.30+$2104.61M → CYTHW
4$109,626,980,731$107,375,032,504.06$16,841$1,302.88+$109626.96M → CYTHW
5$5,344,419,538,811$5,227,118,669,428.94$19,841$1,821.64+$5344419.52M → CYTHW
6$243,874,608,189,950$238,156,079,283,422.40$23,818$2,587.47+$243874608.17M → CYTHW
7$10,417,442,627,867,752$10,156,496,797,104,504.00$29,230$3,744.65+$10417442627.84M → CYTHW
8$416,612,895,336,954,560$405,466,231,725,136,060.00$36,816$5,540.38+$416612895336.92M → CYTHW
9$15,600,306,933,342,350,000$15,154,531,135,331,807,000.00$47,806$8,413.17+$15600306933342.30M → CYTHW
10$547,038,161,900,822,200,000$530,345,833,482,145,900,000.00$64,324$13,170.85+$547038161900822.13M → CYTHW

CYTHW vs EPRT: Complete Analysis 2026

CYTHW — Stock

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Full CYTHW Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this CYTHW vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYTHW vs SCHDCYTHW vs JEPICYTHW vs OCYTHW vs KOCYTHW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.